Baylor College Of Medicine
Clinical trials sponsored by Baylor College Of Medicine, explained in plain language.
-
Suicide Gene-Equipped t cells aim to make stem cell transplants safer
Disease control OngoingThis trial tests whether specially modified T cells from a partially matched donor can help patients recover their immune system faster after a stem cell transplant. The T cells are engineered with a 'suicide gene' that allows doctors to destroy them if they cause graft-versus-ho…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jul 02, 2026 05:00 UTC
-
Engineered t cells with a kill switch aim to make stem cell transplants safer
Disease control OngoingThis study tests a new approach for people receiving a stem cell transplant from a partially matched family donor. The donor's immune cells (T cells) are modified in the lab to include a 'suicide gene' that can be activated by a drug if the cells attack the patient's body, causin…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jul 02, 2026 05:00 UTC
-
Engineered immune cells take aim at tough T-Cell cancers
Disease control OngoingThis early-phase trial tests a new cell therapy for people with hard-to-treat T-cell leukemia or lymphoma. Researchers take a patient's own immune T-cells, modify them in the lab to recognize and attack cancer cells carrying the CD7 protein, and infuse them back. The main goals a…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New vaccine combo aims to outsmart relapsed neuroblastoma in kids
Disease control OngoingThis study tests a tumor vaccine combined with daily low-dose chemotherapy for children whose high-risk neuroblastoma has returned or not responded to standard treatment. The vaccine is designed to train the immune system to recognize and attack neuroblastoma cells, while the low…
Phase: PHASE1, PHASE2 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Experimental T-Cell therapy takes aim at lymphoma
Disease control OngoingThis early-phase trial tests a new therapy for Hodgkin and non-Hodgkin lymphoma that has returned or not responded to standard treatment. Researchers take a patient's own immune cells, train them in the lab to recognize five cancer-specific proteins (tumor-associated antigens), a…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Supercharged immune cells take on tough B-Cell cancers in early trial
Disease control OngoingThis early-phase trial tests a new cell therapy called ANCHOR for people with B-cell lymphoma or leukemia that has returned or not responded to treatment. The therapy uses immune cells from a healthy donor that are engineered to recognize and attack cancer cells carrying the CD19…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Leukemia drug holiday: study tests if patients can pause treatment
Disease control OngoingThis study looks at whether people with chronic myeloid leukemia (CML) who have had a stable, deep response to treatment for at least two years can safely stop taking their daily targeted therapy (TKI). It involves 17 adults who have been on TKI for over three years. The main goa…
Phase: PHASE2 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Family fitness: new program targets hispanic dads to fight childhood obesity
Disease control OngoingThis study tests a 10-week program called Healthy Dads, Healthy Kids for Hispanic families in Houston. Dads aim to lose weight, while kids increase physical activity through group sessions and joint exercise. About 187 fathers and their children are taking part to see if the prog…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Engineered immune cells plus chickenpox vaccine take on childhood cancers
Disease control OngoingThis early-phase study tests a new treatment for advanced osteosarcoma and neuroblastoma that has not responded to standard therapy. Researchers take a patient's own immune cells (T cells), add a gene to help them recognize and attack cancer cells, and combine them with a chicken…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Video counseling boosts HIV med adherence in teens, trial tests
Disease control OngoingThis trial tests a video-based counseling program for adolescents living with HIV in Malawi. About 1,800 teens and their treatment supporters will either receive the video intervention or standard care. The goal is to see if the videos help teens take their medication regularly a…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Engineered t cells take on childhood cancer in early trial
Disease control OngoingThis early-phase trial tests a new type of immune therapy for children with neuroblastoma that has come back or not responded to treatment. Researchers take a patient's own T cells, add new genes to help them recognize and kill neuroblastoma cells and survive longer, then infuse …
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Can a Step-by-Step program help latinos beat fatty liver?
Disease control OngoingThis study looks at whether a 26-week behavioral weight loss program called 'Paso a Paso' is practical for Mexican and Central American adults with fatty liver disease and overweight. Researchers will track attendance, weight loss, liver stiffness, and diet changes in 50 particip…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Donor immune cells show promise against Virus-Linked cancers
Disease control OngoingThis study tests a new treatment for cancers linked to the Epstein-Barr virus (EBV), such as Hodgkin lymphoma and nasopharyngeal carcinoma. The treatment uses immune cells from healthy donors that are specially trained to attack EBV-infected cells. These cells are stored in a ban…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could chewing gum during pregnancy protect Babies' brains?
Disease control OngoingThis study in Malawi tests whether chewing xylitol gum three times a day during pregnancy can improve gum health and change the bacteria in the mouth and vagina. Researchers will also check if it reduces pregnancy complications and affects babies' brain development. 80 pregnant w…
Phase: PHASE1, PHASE2 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Supercharged immune cells take on tough cancers in early human test
Disease control OngoingThis early-phase trial tests a new experimental treatment called CATCH T cells in up to 12 adults with certain solid tumors (like liver cancer or Wilms tumor) that have returned or not responded to standard care. The cells are the patient's own T cells, genetically modified in th…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Engineered immune cells take aim at blood cancers
Disease control OngoingThis early-phase study tests a new treatment for people with certain B-cell blood cancers (lymphoma, ALL, or CLL) that have returned or not responded to standard therapy. The treatment uses the patient's own T cells, which are modified in the lab to recognize and attack cancer ce…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Patch may boost fetal spina bifida repair, early trial hints
Disease control OngoingThis study tests two minimally invasive fetal surgery techniques for repairing neural tube defects (spina bifida) in the womb. One method uses a Durepair patch to reinforce the repair, while the other does not. Researchers aim to see if the patch leads to a thicker repair and few…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Engineered immune cells take aim at Hard-to-Treat lymphoma
Disease control OngoingThis early-phase study tests a new treatment for people with Hodgkin or non-Hodgkin lymphoma that has returned or not responded to standard therapy. Researchers take a patient's own immune cells (T cells), add a special receptor that targets the CD30 protein found on lymphoma cel…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Supercharged immune cells take on nasopharyngeal cancer
Disease control OngoingThis early-stage trial tests whether specially trained immune cells (T cells) that are resistant to a cancer's defense protein (TGF-beta) can safely fight EBV-positive nasopharyngeal carcinoma. Fourteen patients with relapsed or hard-to-treat cancer will receive these gene-modifi…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Engineered immune cells take on sarcoma in early trial
Disease control OngoingThis early-phase trial tests whether specially engineered immune cells (HER2-specific CAR T cells) can safely treat advanced sarcoma that has not responded to standard treatments. Up to 36 participants will receive an infusion of their own modified T cells, with some also getting…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Supercharged t cells take on childhood cancers
Disease control OngoingThis early-phase trial tests a new immunotherapy called AGAR T cells in children with solid tumors such as liver cancer, Wilms tumor, and rhabdomyosarcoma that have returned or not responded to standard care. The cells are made from the patient's own T cells, which are geneticall…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Teen artery stiffness study tests carnitine supplement for heart health
Disease control OngoingThis study looks at whether a protein supplement called carnitine can reduce hardening of the arteries in teenagers at high risk for future heart disease. About 90 teens aged 11-21 with high triglycerides will take carnitine or a placebo. Researchers will measure artery stiffness…
Phase: PHASE2 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Donor immune cells show promise against returning blood cancers
Disease control OngoingThis early-phase study tests a new treatment for people with certain blood cancers (lymphoma or leukemia) that have returned after a stem cell transplant. Researchers take immune cells called T cells from the original stem cell donor, modify them to recognize and attack cancer ce…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New transplant method aims to cut dangerous immune reaction in half-matched donors
Disease control OngoingThis study tests a stem cell transplant method that removes certain immune cells from the donor's blood to lower the chance of graft-versus-host disease (GvHD), a serious complication. It involves 3 patients with blood cancers or non-cancerous blood disorders who lack a perfectly…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Supercharged t cells take on Hard-to-Treat lymphoma
Disease control OngoingThis early-phase trial tests whether specially trained immune cells (T cells) that are made resistant to a tumor's defense chemical can safely fight relapsed EBV-positive lymphoma. Eight patients will receive two injections of these modified cells, 14 days apart, at increasing do…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Supercharged immune cells take on Hard-to-Treat blood cancers
Disease control OngoingThis study tests a new type of immune therapy for people with certain blood cancers (CLL, lymphoma, or multiple myeloma) that have come back or not responded to treatment. Researchers take a patient's own T cells, add a special receptor that targets a protein called kappa on canc…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Could a forehead device stop seizures in veterans?
Disease control OngoingThis study tests whether a non-invasive forehead device called Cefaly, already approved for migraines, can reduce seizures in veterans with drug-resistant epilepsy. Twenty-four veterans will be split into two groups: one gets standard care plus the device, the other gets standard…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Supercharged donor cells take aim at blood cancers
Disease control OngoingThis early-phase trial tests whether specially trained immune cells from a donor can safely target and kill cancer cells in people with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) after a stem cell transplant. The cells are grown in a lab to recognize four prot…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Engineered immune cells take aim at tough leukemia
Disease control OngoingThis early-phase trial tests a new type of cell therapy for adults with acute myeloid leukemia (AML) that has returned or not responded to standard treatment. The therapy uses the patient's own T cells, which are modified in the lab to recognize and attack leukemia cells carrying…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Withdrawn trial sought to protect gut cells in GVHD patients
Disease control TerminatedThis early-phase trial aimed to test whether adding the drug 5-azacytidine (AZA) to standard steroid treatment could protect gut stem cells in patients with gastrointestinal graft-versus-host disease (GVHD), a serious complication after a donor stem cell transplant. The study pla…
Phase: EARLY_PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Engineered t cells take on childhood liver cancer in first human test
Disease control OngoingThis early-phase trial tests a new experimental treatment called GAP T cells in children and young adults with liver cancer that has come back or not responded to standard therapy. The cells are made from the patient's own immune T cells, which are genetically modified to recogni…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 26, 2026 18:58 UTC
-
Supercharged immune cells injected into brain to fight tumors
Disease control OngoingThis early-phase trial tests a new approach for people with HER2-positive brain tumors that have come back or not responded to standard treatment. Researchers take the patient's own T cells, attach a special antibody (anti-HER2) to them, and inject these 'CAR T cells' directly in…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 26, 2026 14:17 UTC
-
Could a mouth rinse spot hidden HPV cancers in men?
Diagnosis OngoingThis study is looking for better ways to find HPV-related throat and anal cancers early in men. Researchers are testing whether a blood test or a simple mouth rinse can spot signs of the virus that might lead to cancer. They plan to follow 1,500 men over time to see if these test…
Sponsor: Baylor College of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 08:14 UTC
-
New ultrasound otoscope aims to spot ear infections with greater accuracy
Diagnosis OngoingThis study tests an advanced ultrasound otoscope, a device that uses sound waves to look inside the ear and detect fluid behind the eardrum. Researchers will compare its readings to the surgeon's findings during ear tube surgery in 300 children up to 12 years old. The goal is to …
Sponsor: Baylor College of Medicine • Aim: Diagnosis
Last updated Jun 26, 2026 16:37 UTC
-
New study aims to close TB prevention gaps for HIV patients
Prevention OngoingThis study looks at better ways to find and prevent tuberculosis (TB) in people living with HIV. Researchers will test a new screening method and offer patients a choice of TB preventive medicines with extra support like text reminders. The goal is to improve TB detection and hel…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Prevention
Last updated Jun 27, 2026 12:38 UTC
-
At-Home HPV test kit aims to boost cervical cancer screening in underserved women
Prevention OngoingThis study tests whether mailing a self-sampling HPV test kit to Asian and underserved women can increase cervical cancer screening rates. Participants receive a kit to collect a sample at home and send it back for testing, along with phone support. The goal is to make screening …
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Prevention
Last updated Jun 27, 2026 07:54 UTC
-
Online therapy could ease anxiety in autistic teens
Symptom relief OngoingThis study tests an internet-based cognitive behavioral therapy (CBT) program designed to help autistic adolescents aged 11-17 manage anxiety. The program, called LUNA-Adolescent, is parent-led and delivered online, making it easier for families who cannot access in-person therap…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
New web program aims to ease burden for dementia caregivers
Symptom relief ENROLLING_BY_INVITATIONThis study tests a web-based support program called Hospital GamePlan4Care for caregivers of veterans with dementia who are discharged from skilled nursing facilities to home. Fifty-five caregivers will receive either the program (website, emails, and phone coaching) or basic hea…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Four-Minute videos could transform anorexia care for teens
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether a series of four short educational videos (each under 7 minutes) can help parents of adolescents with anorexia feel more confident and less stressed. About 50 parent-teen pairs will either receive standard care or standard care plus the videos. Researcher…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New study tackles mom's stress and food needs to boost baby bonding
Symptom relief OngoingThis study aims to help mothers of babies in intensive care cope with depression, anxiety, and stress while also addressing basic needs like food and housing. About 200 caregivers of infants up to 6 months old will receive emotional support and referrals to community resources. T…
Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
New knife may speed up colon polyp removal
Symptom relief OngoingThis study compares a new bipolar knife to a standard monopolar knife for removing colon polyps using a procedure called endoscopic submucosal dissection (ESD). About 80 adults with colon growths will be randomly assigned to one knife. Researchers will measure how fast the proced…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
THC pain study for endometriosis pulled before start
Symptom relief TerminatedThis study aimed to see if a synthetic THC pill (Marinol) could safely reduce chronic pelvic pain in women with endometriosis. It planned to enroll up to 75 women aged 18-64 and give them THC or a placebo for 8 weeks. However, the study was withdrawn before any participants were …
Phase: PHASE2 • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Can online family therapy ease childhood anxiety and OCD?
Symptom relief OngoingThis study compares two low-intensity family treatments for children aged 7-13 with anxiety or obsessive-compulsive disorder (OCD): internet-delivered cognitive behavioral therapy (CBT) and a parent-led reading program. Both are delivered via telehealth and compared to a relaxati…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
Ear acupuncture aimed at cutting opioid use after wrist surgery – but trial never started
Symptom relief TerminatedThis study planned to test whether giving ear acupuncture during wrist fracture surgery could lower the amount of opioid painkillers patients need afterward. It was designed for adults aged 18–64 having a specific type of wrist repair. However, the trial was withdrawn before enro…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Ear acupuncture aimed at cutting opioid use after broken leg surgery – but trial never started
Symptom relief TerminatedThis study planned to test whether adding ear acupuncture to standard pain management could reduce opioid use after surgery for lower leg fractures. It was designed for adults aged 18–64 undergoing ankle or foot fracture repair. However, the trial was withdrawn before enrolling a…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Invisalign offers hope for safer smiles in osteogenesis imperfecta
Symptom relief OngoingThis study tests whether Invisalign clear aligners can safely straighten teeth in people with Osteogenesis Imperfecta (OI), a condition that makes bones brittle and dental work risky. About 57 participants aged 12 to 40 with mild to moderate teeth misalignment will receive treatm…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Scientists hunt for genes behind rare birth defect disorder
Knowledge-focused OngoingThis study aims to learn more about the genetic changes that cause Goltz syndrome, a rare condition that affects the skin, bones, eyes, and other organs. Researchers are collecting blood samples from up to 84 people with the condition and their parents to analyze their DNA. No tr…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
New study aims to detect liver damage without needles
Knowledge-focused OngoingThis study looks at whether simple blood tests and special scans can detect liver scarring in people with urea cycle disorders. Researchers will enroll 62 participants across five U.S. centers. The goal is to find noninvasive ways to monitor liver health, avoiding the need for li…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Brain implant learns to read OCD signals in tiny pilot study
Knowledge-focused OngoingThis early study tests an adaptive deep brain stimulation (aDBS) system in 2 people with severe, treatment-resistant OCD. The device records brain signals to identify patterns linked to OCD distress and stimulation side effects. The goal is not to treat OCD now, but to gather dat…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Brain implant learns to read OCD signals in real time
Knowledge-focused OngoingThis study tests an adaptive deep brain stimulation (aDBS) system in just 3 people with severe, treatment-resistant OCD. The device is implanted in the brain and chest, and it aims to detect brain signals linked to OCD distress and adjust stimulation automatically. The main goal …
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Scientists hunt for hidden genes behind rare pregnancy moles
Knowledge-focused OngoingThis study aims to find the genetic changes that cause some women to have repeated molar pregnancies (abnormal growths in the womb). Researchers will analyze DNA from blood and tissue samples of up to 100 women and their relatives. The goal is to discover new genes linked to this…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Home visits for new moms: a simple idea that could reduce stress and boost confidence
Knowledge-focused OngoingThis study tests a brief home visitation program for pregnant and postpartum women. Half of the 450 participants will receive at least two free home visits from a community health worker, who will provide resources and tools to prepare for the baby. The other half will receive st…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Brain fog fix? antioxidant study targets early memory loss
Knowledge-focused OngoingThis study looks at whether taking supplements that boost glutathione, a natural antioxidant, can help memory in older adults with mild cognitive impairment. Sixty participants will take either the active supplements or a placebo for 12 weeks, then stop for another 12 weeks to se…
Phase: EARLY_PHASE1 • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Breathing problems in brittle bone disease: new study seeks answers
Knowledge-focused OngoingThis study examines lung and heart function in 18 adults with osteogenesis imperfecta (OI), also known as brittle bone disease. Researchers want to understand why breathing problems are the leading cause of death in OI. Participants will undergo lung function tests and chest imag…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Breast milk mouth care may boost gut health in rare birth defect
Knowledge-focused OngoingThis study looks at whether giving oral care with breast milk (or sterile water if breast milk is not available) can improve feeding tolerance and gut bacteria in newborns with gastroschisis, a rare abdominal wall defect. Researchers will follow 27 infants in the NICU to see if t…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Donor Milk's lasting impact on tiny preemies under the microscope
Knowledge-focused OngoingThis study follows about 51 premature infants (born before 37 weeks and weighing 2.75 pounds or less) who received donor human milk in the NICU. Researchers want to see how these babies grow and develop after they go home. The goal is to learn whether an exclusive human milk diet…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Could a High-Protein diet in the NICU boost preemie brain development?
Knowledge-focused TerminatedThis study follows up on extremely low birth weight infants (under 1000 grams) who received either a standard or high-protein diet while in the NICU. Researchers want to see if the higher protein diet leads to better growth, body composition, and neurodevelopment at 18-24 months …
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Brittle bone disease linked to severe teeth misalignment – new study investigates
Knowledge-focused OngoingThis study looks at teeth misalignment and neck defects in people with moderate to severe osteogenesis imperfecta (OI), a rare condition that causes bones to break easily. Researchers will use scans of the teeth, jaw, and neck to measure these problems in 75 participants aged 10 …
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Pee power: urine test may replace needles for brittle bone diagnosis
Knowledge-focused OngoingThis study is testing whether a urine test can help identify different genetic types of osteogenesis imperfecta (OI), a rare condition that causes bones to break easily. Researchers will measure certain collagen peptides in the urine of 25 people with OI. If successful, this coul…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC